Qureight

Qureight is a clinical data curation and AI-powered analytics company based in Cambridge, United Kingdom. Founded in 2018, its mission is to enhance the understanding of lung and heart diseases by improving clinical trials through advanced imaging and data platforms. The company combines expertise from clinicians, radiologists, and data scientists to analyze and utilize anonymized imaging, clinical data, and biomarkers. As a Core Imaging Laboratory, Qureight offers AI-driven data curation services, including rapid review of clinical trial images, creation of synthetic control arms, and analysis of imaging and clinical data to identify new endpoints. Its flagship product, AI Lung, features 3D imaging tools that serve as image-based endpoints in global trials for conditions like Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension. Qureight collaborates with various biopharma companies and research organizations to drive innovation in drug development for lung and heart diseases.